Takeda Pharmaceutical Company Limited - Company & Market Research Reports

Home /
Companies /
Takeda Pharmaceutical Company Limited

Takeda Pharmaceuticals is the largest pharmaceutical company in Asia and a top 15 pharmaceutical company in the world. It provides products in various therapeutic areas, including gastroenterology, oncology, central nervous system, cardiovascular and metabolic, vaccines, and others. Takeda was founded in 1781 and operates two primary bases in Japan in Osaka and Tokyo. Its global operations are based in Zurich, Switzerland.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 189
Endocrine and Metabolic Disorders Drugs 165
Gastrointestinal Drugs 147
Immune Disorders Drugs 128
Central Nervous System Drugs 127
Biopharmaceuticals 88
Pharmaceuticals 85
Hematological Drugs 79
Vaccines 77
Clinical Trials 67
Drug Discovery 63
Cardiovascular Drugs 60
Diabetes Drugs 55
Leukemia Drugs 52
Infectious Diseases Drugs 51
Mental Disorders Drugs 46
Lymphoma Drugs 42
Musculoskeletal Disorders Drugs 40
Liver and Kidney Disorders Drugs 32
Infusions and Injectables 31
Over the Counter (OTC) Drugs 30
Lung Cancer Drugs 24
Sexual and Reproductive Health Drugs 20
Drug Delivery 19
Respiratory Drugs 18
Pharmaceutical Manufacturing 17
Antibiotics 16
Analgesics 15
Drugs by Therapeutic Area 13
Immunosuppressive Drugs 13
Pharmaceutical Intermediates 12
Schizophrenia Drugs 12
Prostate Cancer Drugs 11
Skin Cancer Drugs 11
Optical Disorders Drugs 10
Anti-Obesity Drugs 9
Alzheimer's Disease Drugs 9
Generic Drugs 7
Biosimilars and Biosuperiors 7
Psoriasis Drugs 7
Addiction Disorders Drugs 6
Animal Pharmaceuticals 6
Colon Cancer Drugs 6
Transdermal and Transmucosal Drug Delivery 6
Thyroid Cancer Drugs 6
Uterine Cancer Drugs 6
Dermatological Drugs 6
Urological Disorders Drugs 6
Liver Cancer Drugs 4
Cervical Cancer Drugs 4
Brain Cancer Drugs 4
Cough and Cold Drugs 4
Company Reports 3
Breast Cancer Drugs 3
Kidney Cancer Drugs 3
HIV/AIDS Drugs 3
Ovarian Cancer Drugs 2
Anesthetic Drugs 2
Cancer Vaccines 2
Pancreatic Cancer Drugs 2
Vitamins and Dietary Supplements 2
Pharmacoeconomics 1
Inhalers and Nebulisers 1
Anxiety Drugs 1
Bronchitis Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



287 reviews

1,644 Results (Page 31 of 83)
- Relevance
  Sort by

Rare Diseases Market Report 2024-2034

 Report
May 2024
344 Pages
Global

From

€5377EUR$6,007USD£4,350GBP

Atypical Teratoid Rhabdoid Tumors (ATRT)- Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1158EUR$1,250USD£970GBP

Systemic Psoriasis Therapeutics - Global Strategic Business Report

 Report
October 2026
192 Pages
Global

From

€5420EUR$5,850USD£4,538GBP

Metabolic Syndrome Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application

 Report
April 2025
90 Pages
Global

From

€3500EUR$4,047USD£3,033GBP

Oral Anti-Diabetic Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2018 - 2029

 Report
February 2024
150 Pages
Global

From

€4401EUR$4,750USD£3,685GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Japan Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Japan

From

€4401EUR$4,750USD£3,685GBP

Italy Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Italy

From

€4401EUR$4,750USD£3,685GBP

New Zealand Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4401EUR$4,750USD£3,685GBP

North America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
North America

From

€4401EUR$4,750USD£3,685GBP

Asia-Pacific Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Asia Pacific

From

€4401EUR$4,750USD£3,685GBP

Latin America Oral Anti-Diabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
Latin America

From

€4401EUR$4,750USD£3,685GBP

New Zealand Insulin Drugs and Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
New Zealand

From

€4401EUR$4,750USD£3,685GBP

South Africa Oral Antidiabetic Drug - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
70 Pages
South Africa

From

€4401EUR$4,750USD£3,685GBP

Endocrinology Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

 Report
February 2024
110 Pages
Global

From

€4401EUR$4,750USD£3,685GBP

Benign Prostatic Hyperplasia (BPH) Drugs - Global Strategic Business Report

 Report
October 2026
210 Pages
Global

From

€5420EUR$5,850USD£4,538GBP

Prostate Cancer Therapeutics - Global Strategic Business Report

 Report
October 2026
217 Pages
Global

From

€5420EUR$5,850USD£4,538GBP

Alofisel

 Report
August 2018
21 Pages
Global

From

€9265EUR$10,000USD£7,758GBP

Alzheimer's Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030

 Drug Pipelines
May 2023
151 Pages
Global

From

€13892EUR$14,995USD£11,633GBP

Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

 Report
December 2022
1560 Pages
Global

From

€2316EUR$2,500USD£1,939GBP

Primary Hyperoxaluria Treatment Market Report and Forecast 2023-2031

 Report
April 2023
147 Pages
Global

From

€4585EUR$4,949USD£3,839GBP

1,644 Results (Page 31 of 83)
- 1
- 29
- 30
- 31
- 32
- 33

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.